INDAPTUS THERAPEUTICS INC (INDP) Stock News

NASDAQ:INDP - US45339J1051 - Common Stock

4.19 USD

-0.42 (-9.11%)

Last: 9/5/2025, 11:54:19 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

INDP Latest News, Press Relases and Analysis

All

Press Releases

4 hours ago - By: Benzinga - Mentions: NBY PHR IMCC PMN ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

19 hours ago - By: Benzinga - Mentions: COR PHR FBIO RLMD ...

12 Health Care Stocks Moving In Thursday's After-Market Session

20 hours ago - By: Indaptus Therapeutics

Indaptus Therapeutics Provides Clinical Update

23 days ago - By: The Motley Fool

Indaptus Posts Narrower Loss in Q2

23 days ago - By: Indaptus Therapeutics

Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

2 months ago - By: Indaptus Therapeutics

Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants

2 months ago - By: Indaptus Therapeutics

Indaptus Therapeutics Announces Reverse Stock Split

3 months ago - By: Indaptus Therapeutics

Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants

4 months ago - By: Indaptus Therapeutics

Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

4 months ago - By: Indaptus Therapeutics

Indaptus Therapeutics Founder and Chief Scientific Officer Dr. Michael Newman Named Chair and Expert Speaker at 6th Annual Cytokine-Based Drug Development Summit

5 months ago - By: Indaptus Therapeutics

Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360 Summit

6 months ago - By: Indaptus Therapeutics

Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update